---
title: "BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300618358.md"
description: "BioStem Technologies raised $3 million via private placement, issuing shares at $4.08 and warrants exercisable at $3.83. Proceeds support working capital. The company signed a Registration Rights Agreement to file resale registration within 30 days, enhancing investor liquidity."
datetime: "2026-09-30T20:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300618358.md)
  - [en](https://longbridge.com/en/news/300618358.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300618358.md)
generator: "portal-rs"
---

# BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants

BioStem Technologies raised approximately $3.0 million through a private placement with institutional investors, issuing 735,296 common shares at $4.08 per share and Series A and Series B warrants exercisable for up to 1,470,592 additional shares at $3.83. The placement closed on September 30, 2026, with proceeds earmarked for working capital and general corporate purposes. In a related move, the company executed a Registration Rights Agreement to file a resale registration within 30 days and target effectiveness within 45 days, or 75 days under a full SEC review, enhancing investor liquidity.

**Agreement 1: BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants**

-   **Agreement type**: Securities Purchase Agreement for private placement of equity and warrants
-   **Counterparty**: Certain institutional investors
-   **Signed / Effective**: Sep 29 2026 / Sep 29 2026
-   **Reason**: Raise working capital and general corporate funds

**Agreement 2: BioStem Technologies Sets Investor Registration Timeline for Shares and Warrant Stock**

-   **Agreement type**: Registration Rights Agreement for resale of shares and warrant shares
-   **Counterparty**: Certain institutional investors
-   **Signed / Effective**: Sep 29 2026 / Sep 29 2026
-   **Reason**: Provide resale liquidity for investors

Original SEC Filing: BioStem Technologies, Inc. \[ BSEM \] - 8-K - Sep. 30, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BSEM.US](https://longbridge.com/en/quote/BSEM.US.md)

## Related News & Research

- [BioStem Technologies’ CEO and COO invest $1M in cash through exercise of stock options](https://longbridge.com/en/news/301268750.md)
- [BioStem secures USD 40 million equity facility via private placement with Roth affiliate](https://longbridge.com/en/news/299437694.md)
- [BE: Revenue rose 138% YoY as margins expanded and FY2026 guidance was raised again](https://longbridge.com/en/news/302787538.md)
- [TTM Technologies Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into TTM Technologies (TTMI)](https://longbridge.com/en/news/302793872.md)
- [GRAPHIC-Take Five: AI trade meets the Fed](https://longbridge.com/en/news/302836715.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**